JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
James C. Stringham
James H. Southard
Robert M. Mentzer, Jr.
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stringham, J. C.
Right arrow Articles by Belzer, F. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stringham, J. C.
Right arrow Articles by Belzer, F. O.

J Thorac Cardiovasc Surg 1994;107:764-775
© 1994 Mosby, Inc.


CARDIAC AND PULMONARY TRANSPLANTATION

Prolonging myocardial preservation with a modified University of Wisconsin solution containing 2,3-butanedione monoxime and calcium

James C. Stringham, MDa, Karen L. Paulsen, BSa, James H. Southard, PhDb, Robert M. Mentzer, Jr., MDa, Folkert O. Belzer, MDb


Madison, Wis.

Supported by grants from the University of Wisconsin School of Medicine and the University of Wisconsin Surgical Associates.

Received for publication April 9, 1993. Accepted for publication Aug. 20, 1993. Address for reprints: James Stringham, MD, Division of Cardiothoracic Surgery, University of Wisconsin Hospitals and Clinics, 600 Highland Ave., Madison, WI 53792.

Abstract

The University of Wisconsin solution is an effective preservative for cold storage of the cardiac allograft. In an earlier study we showed that addition of calcium and 2,3-butanedione monoxime, a reversible inhibitor of myocardial contracture, further improved preservation of the rabbit heart. In this study we investigated the following: (1) the effects of different concentrations of 2,3-butanedione monoxime and calcium on function of the preserved rabbit heart, (2) how heart preservation is affected when 2,3-butanedione monoxime and calcium are added to the St. Thomas' Hospital and Stanford solutions, and (3) how 2,3-butanedione monoxime and calcium, at optimal concentrations in University of Wisconsin solution, affect hearts preserved up to 48 hours. Rabbit hearts were flushed with preservative and stored at 4° C for 24, 30, 40, or 48 hours. Myocardial function was assessed during 60 minutes of isolated reperfusion, and myocardial adenine nucleotide content was measured after completion of reperfusion. Three concentrations of 2,3-butanedione monoxime (15, 30, and 60 mmol/ L) in the University of Wisconsin solution were studied in hearts preserved for 30 hours. Storage with 2,3-butanedione monoxime at 30 mmol/L resulted in significantly better left ventricular developed pressure (p < 0.01), left ventricular end-diastolic volume (p < 0.01), rate of left ventricular pressure rise (p < 0.01), coronary flow (p < 0.05), rate-pressure product (p < 0.001), and adenine nucleotide regeneration (p < 0.05) than with 60 mmol/L, although function was not significantly different when the osmolarity of the solutions was equalized. There was significant reduction in end-diastolic volume (p < 0.05) and adenine nucleotide recovery (p < 0.01) when 2,3-butanedione monoxime was lowered to 15 mmol/L. Decreasing the calcium concentration from 1.0 to 0.1 mmol/L also had a deleterious effect on myocardial function (p < 0.05). The addition of 30 mmol/L 2,3-butanedione monoxime and 1.0 mmol/L calcium to the St. Thomas' or Stanford solutions improved preservation of the heart when compared with the unmodified solutions, but to a lesser degree than with the modified University of Wisconsin solution. After 24 to 48 hours of storage in University of Wisconsin solution containing 30 mmol/L 2,3-butanedione monoxime and 1.0 mmol/L calcium, there was substantial improvement in developed pressure (p < 0.001), end-diastolic volume (p < 0.05), and rate pressure product (p < 0.001), although there was little effect on heart rate and coronary flow, when compared with the unmodified University of Wisconsin solution. We conclude that modification of the University of Wisconsin solution with 30 mmol/L 2,3-butanedione monoxime and 1.0 mmol/L calcium significantly improves long-term preservation of the rabbit heart. Further extension in preservation might be accomplished by optimizing the osmolarity of this modified solution. (J THORACCARDIOVASCSURG1994;107:764-75)




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
Y. Talmor-Barkan, G. Rashid, I. Weintal, J. Green, J. Bernheim, and S. Benchetrit
Low extracellular Ca2+: a mediator of endothelial inflammation
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3306 - 3312.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Warnecke, B. Schulze, C. Hagl, A. Haverich, and U. Klima
Improved right heart function after myocardial preservation with 2,3-butanedione 2-monoxime in a porcine model of allogenic heart transplantation
J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Habazettl, J. Voigtlander, R. Leiderer, and K. Messmer
Efficacy of myocardial initial reperfusion with 2,3 butanedione monoxime after cardioplegic arrest is time-dependent
Cardiovasc Res, March 1, 1998; 37(3): 684 - 690.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Zhang, R. D. Furukawa, S. E. Fremes, D. A. G. Mickle, and R. D. Weisel
Effects of Butanedione Monoxime and Temperature on Prolonged Cardiac Storage
Ann. Thorac. Surg., February 1, 1997; 63(2): 388 - 394.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. H. Dorman, M. J. Cavallo, R. B. Hinton, R. C. Roy, and F. G. Spinale
PRESERVATION OF MYOCYTE CONTRACTILE FUNCTION AFTER HYPOTHERMIC, HYPERKALEMIC CARDIOPLEGIC ARREST WITH 2,3-BUTANEDIONE MONOXIME
J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 621 - 629.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Habazettl, B. W. Palmisano, B. M. Graf, D. L. Roerig, Z. J. Bosnjak, and D. F. Stowe
IMPROVEMENT IN FUNCTIONAL RECOVERY OF THE ISOLATED GUINEA PIG HEART AFTER HYPERKALEMIC REPERFUSION WITH ADENOSINE
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 74 - 84.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. Ingemansson, T. Sjoberg, G. Massa, and S. Steen
Long-Term Preservation of Vascular Endothelium and Smooth Muscle
Ann. Thorac. Surg., May 1, 1995; 59(5): 1177 - 1181.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The American Association for Thoracic Surgery.